688
Participants
Start Date
October 14, 2015
Primary Completion Date
August 14, 2017
Study Completion Date
October 24, 2017
Boostrix™
One dose administered intramuscularly in the deltoid muscle of the non-dominant arm.
Saline placebo
One dose administered intramuscularly in the deltoid muscle of the non-dominant arm.
GSK Investigational Site, Parkville
GSK Investigational Site, Carlton
GSK Investigational Site, Fitzroy
GSK Investigational Site, Turin
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Turku
GSK Investigational Site, Aravaca
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Novara
GSK Investigational Site, Majadahonda (Madrid)
GSK Investigational Site, Boadilla del Monte
GSK Investigational Site, Móstoles
GSK Investigational Site, Málaga
GSK Investigational Site, Antequera/Málaga
GSK Investigational Site, Tampere
GSK Investigational Site, Seville
GSK Investigational Site, Seville
GSK Investigational Site, Seinäjoki
GSK Investigational Site, Kokkola
GSK Investigational Site, Oulu
GSK Investigational Site, Calgary
GSK Investigational Site, Halifax
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Montreal
GSK Investigational Site, Mount Royal
GSK Investigational Site, Brno
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Ostrava - Vitkovice
GSK Investigational Site, Burgos
Lead Sponsor
GlaxoSmithKline
INDUSTRY